| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | -0.057 | 0.3 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | -0.055 | 0.3 |
| mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | -0.053 | 0.3 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.3 |